SOLACI Research Registries Continue to Grow

SOLACI Research department put us up to speed on their Research Registry progress during SOLACI-CACI 2024. Similarly, they shared the outcomes of the Latin American Clinical Guidelines carried out together with the Inter American Society of Cardiology: TAVR vs SAVR in Patients with Severe Aortic Stenosis (2021) and PCI vs CABG in Left Main Disease (2023). 

The presentation was held on August 8, 2024 at the Hilton Hotel Convention Center in Buenos Aires, room Buen Ayre C. The aim of this session was to share the Latin American experience with SOLACI Registries in different interventional cardiology scenarios. 

At the start of this session, Dr. Lucio Padilla (ARG) presented data from the Latin American Registry of Coronary Bifurcation Percutaneous Intervention – LATAM Bif -, so far enrolling over 2000 patients. During his presentation, Dr. Padilla, the main registry researcher, analyzed registry patient characteristics, bifurcation types we deal with in Latin America, the different bifurcation PCI strategies in LATAM, and of course the initiative outcomes. 

Padilla-SOLACI-LATAMBIF-registry-FINAL

Dr. Gustavo Pedernera (ARG) followed with progress made on the LATAM SOLACI Peripheral Registry, this year reaching 1760 patients. During his talk, Dr. Pedernera reminded us of the main objectives of this novel research initiative (seeing as there are no other registries on lower limb angioplasty in our region) detailing the main stats and characteristics of data collected so far. Over the end, the Argentinian doctor pointed out that “being able to count on a registry shared with the whole of LATAM, with reliable data, will enable us to know and improve the treatment of peripheral artery disease, reducing amputations and cardiovascular risk.” 

registr-periferic-gustav-pedernera

Next, Dr. Henrique Ribeiro (BRA) presented the TAVR vs SAVR Clinical Guidelines in Patients with Severe Aortic Stenosis, and Dr. Pablo Lamelas (ARG), SOLACI Research Director, shared PCI vs CABG Guidelines in Left Main Disease, both product of the joint effort of SOLACI and the Inter American Society of Cardiology. 

The discussion panel was comprised of reputed medical doctors in the region such as Dr. Guering Eid-Lidt, Ernesto Torresani (ARG), Alfredo Bravo (ARG), Marcelo Halac (ARG), José Abelardo López (VEN) and Jesús García (VEN). In addition, Dr. José Leonidas Alves Jr presented a report on Katana Thrombectomy System cases. 

If you wish to make part of SOLACI Research Registries or should you have any questions, please write to research@solaci.org


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Más artículos de este Autor

SOLACI Technicians Webinar – Ultrasound Pulses + Calcium = Coronary Lithotripsy

The Latin American Society of Interventional Cardiology (SOLACI) invites you to participate in a new Live SOLACI Webinar specially designed for technicians, nurses, and...

COMPLICAT 2026: Collaborative learning to address complications in congenital and structural heart disease

Free online course in Spanish5 webinars in 2026 COMPLICAT 2026 returns with its second edition, consolidating itself as an innovative academic space dedicated to the...

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

The Latin American Society of Interventional Cardiology invites the entire medical community to participate in a virtual workshop on complications organized by SOLACI’s Complex...

Fellow’s Corner 2026 – Submit Your Clinical Case

Share your experience. Learn from experts. Grow as an interventional cardiologist. The Latin American Society of Interventional Cardiology (SOLACI) is relaunching this year the Fellow’s...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Artículos relacionados

Jornadas SOLACIspot_img

Artículos recientes

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...